The webinar includes key changes in the 2026 Code of Conduct and Adverse Event Reporting (AER) guidelines, together with updates on hot topics including:

• FAMHP (Belgium) article 10 guidance and Market Research
• Key insights from ‘declaration process for market research with HCPs in France’ survey
• EPHMRA Data Fraud survey and becoming a GDQ partner.

The webinar will:

• Highlight the main changes in the 2026 Code of Conduct and AER guidelines.
• Provide a clear update on EPHMRA’s efforts with other leading industry associations to address the issues raised by the introduction of Belgium’s FAMHP guidelines on Art. 10 and the impact on healthcare Market Research.
• Cover key insights from EPHMRA’s member survey to understand the effects of France’s CNOM/CNOP declaration process for market research organisations and next steps.
• Present EPHMRA’s Data Fraud survey and what it means for EPHMRA becoming a GDQ partner.

Target Audience

This webinar is designed for professionals working in:

• Pharmaceutical, Diagnostics and Medical Devices companies
• Market Research agencies
• Fieldwork agencies
• Consulting companies who conduct market research

It is particularly relevant for professionals operating in:

• Market Research / Insights
• Fieldwork and panel management
• Product Management
• Business Development
• Compliance & Privacy

Key Takeaways for Attendees

• Understand key changes in the 2026 Code of Conduct and AER guidelines.
• Learn about how EPHMRA is supporting members and the industry addressing key issues.
• Learn about EPHMRA’s role in data quality and fraud and future resources to support members.
• Recognise the importance of ethics and compliance in our work in healthcare market research.

Presented by:

Kaleke Kolawole, Policy Manager, Market Research Society (UK) & Head of Policy - EFAMRO

Georgina Butcher, EPHMRA Ethics